United States: Yearly Stock Market Performance Insight - 1994
View Detailed Market Cap Breakdown
| Market Cap | Yearly Gainers | Yearly Losers | Average Return | Total Stocks |
|---|---|---|---|---|
| Mega Cap | 20 | 9 | 12.57% | 30 |
| Large Cap | 137 | 162 | 5.66% | 320 |
| Mid Cap | 110 | 168 | -4.10% | 300 |
| Small Cap | 35 | 55 | -4.12% | 102 |
Yearly Streak Leaders for 1994
| Stock | Streak | Streak Return |
|---|---|---|
Coca-Cola | KO
Consumer Defensive
|
Mega Cap
|
14 years โ | 1,714.08% |
|
Coca-Cola continues its impressive multi-year expansion with a 14-year growth streak (0.71 โ 12.88), delivering 1,714.1% cumulative returns. Annual financials validate this performance: 11.1B revenue generating 3.3B net profit (30.0% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025. |
||
Procter & Gamble | PG
Consumer Defensive
|
Mega Cap
|
11 years โ | 336.62% |
|
Procter & Gamble continues its impressive multi-year expansion with a 11-year growth streak (3.55 โ 15.50), delivering 336.6% cumulative returns. Annual financials validate this performance: 19.8B revenue generating 3.8B net profit (19.2% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025. |
||
Walmart | WMT
Consumer Defensive
|
Mega Cap
|
2 years โ | -33.71% |
|
Walmart sees continued yearly losses with a 2-year decline (5.34 โ 3.54), down 33.7% cumulatively. Weak margins on 165.6B annual revenue with only 4.6B profit (2.8% margin) in Qtr ending Apr 2025 validate market skepticism. Structural improvements needed before recovery. |
||
|
B
Bank of America | BAC
Financial Services
|
Mega Cap
|
2 years โ | -12.63% |
|
Bank of America encounters consecutive annual declines with a 2-year decline (12.91 โ 11.28), down 12.6% cumulatively. Weak margins on 27.4B annual revenue with only 7.4B profit (27.0% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery. |
||
Illinois Tool Works | ITW
Industrials
|
Large Cap
|
14 years โ | 1,284.81% |
|
Illinois Tool Works solidifies its market leadership with a 14-year growth streak (0.79 โ 10.94), delivering 1,284.8% cumulative returns. Annual financials validate this performance: 3.8B revenue generating 700.0M net profit (18.2% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025. |
||
Danaher | DHR
Healthcare
|
Large Cap
|
12 years โ | 3,028.57% |
|
Danaher demonstrates exceptional long-term growth with a 12-year growth streak (0.07 โ 2.19), delivering 3,028.6% cumulative returns. Annual financials validate this performance: 5.7B revenue generating 954.0M net profit (16.6% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025. |
||
Biogen | BIIB
Healthcare
|
Large Cap
|
3 years โ | -83.87% |
|
Biogen sees continued yearly losses with a 3-year decline (2.17 โ 0.35), down 83.9% cumulatively. Weak margins on 2.4B annual revenue with only 240.5M profit (9.9% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery. |
||
Labcorp Holdings | LH
Healthcare
|
Large Cap
|
3 years โ | -54.70% |
|
Labcorp Holdings navigates difficult years with a 3-year decline (62.82 โ 28.46), down 54.7% cumulatively. Annual revenue of 3.3B provides stability, but 213.0M net income (6.4% margin) in Qtr ending Mar 2025 highlights operational challenges requiring strategic shifts. |
||
Mattel | MAT
Consumer Cyclical
|
Mid Cap
|
7 years โ | 712.12% |
|
Mattel solidifies its market leadership with a 7-year growth streak (1.98 โ 16.08), delivering 712.1% cumulative returns. Despite 826.6M in annual revenue and - 40.3M loss (-4.9% margin) as of Qtr ending Mar 2025, the market values future potential over current profitability. Long-term investors bet on turnaround. |
||
Sealed Air | SEE
Consumer Cyclical
|
Mid Cap
|
7 years โ | 723.64% |
|
Sealed Air continues its impressive multi-year expansion with a 7-year growth streak (1.10 โ 9.06), delivering 723.6% cumulative returns. Financial performance supports steady gains with 1.3B annual revenue yielding 113.5M profit (Qtr ending Mar 2025). The 8.9% margin provides buffer for continued expansion. |
||
Exponent | EXPO
Industrials
|
Mid Cap
|
4 years โ | -75.00% |
|
Exponent endures extended market pressure with a 4-year decline (2.12 โ 0.53), down 75.0% cumulatively. Weak margins on 145.5M annual revenue with only 26.6M profit (18.3% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery. |
||
Repligen | RGEN
Healthcare
|
Mid Cap
|
3 years โ | -88.52% |
|
Repligen sees continued yearly losses with a 3-year decline (15.25 โ 1.75), down 88.5% cumulatively. Weak margins on 169.2M annual revenue with only 5.8M profit (3.4% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery. |
||
Marten Transport | MRTN
Industrials
|
Small Cap
|
5 years โ | 377.27% |
|
Marten Transport continues its impressive multi-year expansion with a 5-year growth streak (0.22 โ 1.05), delivering 377.3% cumulative returns. With 223.2M annual revenue generating only 4.3M profit (1.9% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead. |
||
Benchmark | BHE
Technology
|
Small Cap
|
4 years โ | 370.18% |
|
Benchmark maintains steady growth trajectory with a 4-year growth streak (1.14 โ 5.36), delivering 370.2% cumulative returns. With 631.8M annual revenue generating only 3.6M profit (0.6% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead. |
||
Biolife Solutions | BLFS
Healthcare
|
Small Cap
|
3 years โ | 0.00% |
|
Biolife Solutions sees continued yearly losses with a 3-year decline (0.00 โ 210.00), down 0.0% cumulatively. Financial struggles compound yearly losses: despite 23.9M annual revenue, - 448,000 losses persist (-1.9% margin) as of Qtr ending Mar 2025. Turnaround remains elusive. |
||
Safehold | SAFE
Real Estate
|
Small Cap
|
2 years โ | -96.59% |
|
Safehold encounters consecutive annual declines with a 2-year decline (481.89 โ 16.43), down 96.6% cumulatively. Yet fundamentals remain solid: 91.9M annual revenue generating 26.1M profit (28.4% margin) as of Qtr ending Dec 2024 suggests this could be a value opportunity. Contrarian investors take note. |
||
United States Market Yearly Gainers & Losers: 1994
Top United States Stock Gainers (1994)
| Stock | Year Open | Year Close | Yearly Change | Avg Daily Volume | Year Volume |
|---|---|---|---|---|---|
Intuit | INTU
Technology
|
Mega Cap
|
$3.54 | $5.56 | 56.62% | 2.5M | 618.9M |
Oracle | ORCL
Technology
|
Mega Cap
|
$1.42 | $2.18 | 53.52% | 45.4M | 11.5B |
Microsoft | MSFT
Technology
|
Mega Cap
|
$2.52 | $3.82 | 51.59% | 67.4M | 17.0B |
Advanced Micro | AMD
Technology
|
Mega Cap
|
$8.88 | $12.44 | 40.09% | 2.1M | 527.5M |
Apple | AAPL
Technology
|
Mega Cap
|
$0.26 | $0.35 | 34.62% | 226.8M | 57.2B |
Hubbell | HUBB
Industrials
|
Large Cap
|
$2.80 | $25.36 | 805.71% | 7.7K | 1.9M |
Hologic | HOLX
Healthcare
|
Large Cap
|
$0.56 | $1.88 | 241.82% | 513.2K | 129.3M |
Cooper Companies | COO
Healthcare
|
Large Cap
|
$0.26 | $0.84 | 223.08% | 360.6K | 90.9M |
Fair Isaac | FICO
Technology
|
Large Cap
|
$3.33 | $8.33 | 150.15% | 104.2K | 26.3M |
Coherent | COHR
Technology
|
Large Cap
|
$0.20 | $0.49 | 145.00% | 162.6K | 41.0M |
Bio-Rad Laboratories | BIO
Healthcare
|
Mid Cap
|
$3.42 | $9.25 | 177.78% | 51.9K | 13.1M |
Robert Half | RHI
Industrials
|
Mid Cap
|
$2.18 | $4.00 | 82.65% | 376.0K | 94.7M |
Cognex | CGNX
Technology
|
Mid Cap
|
$1.84 | $3.22 | 75.00% | 974.9K | 245.7M |
Caci International | CACI
Technology
|
Mid Cap
|
$2.94 | $5.06 | 72.11% | 153.1K | 38.6M |
Sterling | STRL
Industrials
|
Mid Cap
|
$2.09 | $3.50 | 67.46% | 6.3K | 1.6M |
Conmed | CNMD
Healthcare
|
Small Cap
|
$3.19 | $8.83 | 180.32% | 77.3K | 19.5M |
Barrett Business | BBSI
Industrials
|
Small Cap
|
$1.15 | $2.33 | 102.61% | 185.2K | 46.7M |
Rogers | ROG
Technology
|
Small Cap
|
$6.56 | $12.44 | 90.51% | 33.6K | 8.5M |
Photronics | PLAB
Technology
|
Small Cap
|
$5.33 | $9.92 | 86.12% | 118.1K | 29.8M |
ManpowerGroup | MAN
Industrials
|
Small Cap
|
$17.50 | $28.12 | 59.59% | 266.3K | 67.1M |
Biggest United States Stock Losers (1994)
| Stock | Year Open | Year Close | Yearly Change | Avg Daily Volume | Year Volume |
|---|---|---|---|---|---|
Costco Wholesale | COST
Consumer Defensive
|
Mega Cap
|
$9.56 | $6.44 | -33.06% | 2.4M | 606.7M |
Walmart | WMT
Consumer Defensive
|
Mega Cap
|
$4.23 | $3.54 | -15.11% | 15.7M | 4.0B |
JPMorgan Chase | JPM
Financial Services
|
Mega Cap
|
$13.38 | $11.96 | -10.61% | 2.9M | 724.3M |
|
B
Bank of America | BAC
Financial Services
|
Mega Cap
|
$12.22 | $11.28 | -7.92% | 3.0M | 760.2M |
Wells Fargo | WFC
Financial Services
|
Mega Cap
|
$6.06 | $5.84 | -4.11% | 2.4M | 596.5M |
Regeneron | REGN
Healthcare
|
Large Cap
|
$15.50 | $3.00 | -80.65% | 109.3K | 27.5M |
Biogen | BIIB
Healthcare
|
Large Cap
|
$0.92 | $0.35 | -63.54% | 203.1K | 51.2M |
Leonardo DRS | DRS
Industrials
|
Large Cap
|
$142.50 | $56.25 | -60.00% | 2.4K | 610.1K |
Primo Brands | PRMB
Consumer Defensive
|
Large Cap
|
$24.38 | $9.81 | -59.76% | 1.0M | 260.1M |
Southwest Airlines | LUV
Industrials
|
Large Cap
|
$7.36 | $3.31 | -55.15% | 3.9M | 972.4M |
Arrowhead | ARWR
Healthcare
|
Mid Cap
|
$1,787.50 | $45.50 | -97.45% | 12 | 3.0K |
Repligen | RGEN
Healthcare
|
Mid Cap
|
$7.00 | $1.75 | -74.56% | 76.1K | 19.2M |
Excelerate Energy | EE
Energy
|
Mid Cap
|
$2.62 | $0.81 | -69.89% | 75.6K | 19.0M |
Alkermes plc | ALKS
Healthcare
|
Mid Cap
|
$3.75 | $1.06 | -69.71% | 84.4K | 21.3M |
Central Garden & Pet | CENT
Consumer Defensive
|
Mid Cap
|
$12.25 | $4.12 | -67.04% | 22.9K | 5.8M |
Celldex Therapeutics | CLDX
Healthcare
|
Small Cap
|
$1,417.50 | $450.00 | -67.74% | 353 | 88.8K |
Dynex Capital | DX
Real Estate
|
Small Cap
|
$171.75 | $63.75 | -62.88% | 16.1K | 4.1M |
Innodata | INOD
Technology
|
Small Cap
|
$1.75 | $0.81 | -53.71% | 71.9K | 18.1M |
QuidelOrtho | QDEL
Healthcare
|
Small Cap
|
$4.50 | $2.44 | -45.78% | 106.1K | 26.7M |
UFP Technologies | UFPT
Healthcare
|
Small Cap
|
$5.50 | $3.00 | -45.45% | 14.1K | 3.5M |
Most Active United States Stocks During 1994
| Stock | Year Open | Year Close | Yearly Change | Avg Daily Volume | Yearly Volume |
|---|---|---|---|---|---|
Apple | AAPL
Technology
|
Mega Cap
|
$0.26 | $0.35 | 34.62% | 226.8M | 57.2B |
Cisco Systems | CSCO
Technology
|
Mega Cap
|
$1.79 | $1.95 | 8.33% | 79.3M | 20.0B |
Microsoft | MSFT
Technology
|
Mega Cap
|
$2.52 | $3.82 | 51.59% | 67.4M | 17.0B |
Oracle | ORCL
Technology
|
Mega Cap
|
$1.42 | $2.18 | 53.52% | 45.4M | 11.5B |
Walmart | WMT
Consumer Defensive
|
Mega Cap
|
$4.23 | $3.54 | -15.11% | 15.7M | 4.0B |
Intel | INTC
Technology
|
Large Cap
|
$3.89 | $3.99 | 2.84% | 75.2M | 19.0B |
Applied Materials | AMAT
Technology
|
Large Cap
|
$2.42 | $2.64 | 9.09% | 19.5M | 4.9B |
Lam Research | LRCX
Technology
|
Large Cap
|
$1.08 | $1.24 | 14.81% | 14.8M | 3.7B |
Starbucks | SBUX
Consumer Cyclical
|
Large Cap
|
$0.69 | $0.86 | 22.86% | 14.2M | 3.6B |
Tjx Companies | TJX
Consumer Cyclical
|
Large Cap
|
$0.91 | $0.49 | -46.15% | 12.7M | 3.2B |
Gap | GAP
Consumer Cyclical
|
Mid Cap
|
$5.81 | $4.52 | -22.47% | 5.1M | 1.3B |
International Game | IGT
Consumer Cyclical
|
Mid Cap
|
$7.34 | $3.94 | -46.61% | 4.3M | 1.1B |
SLM | SLM
Financial Services
|
Mid Cap
|
$1.54 | $1.11 | -27.45% | 4.1M | 1.0B |
Bath & Body Works | BBWI
Consumer Cyclical
|
Mid Cap
|
$6.85 | $7.20 | 6.67% | 2.6M | 653.1M |
Gentex | GNTX
Consumer Cyclical
|
Mid Cap
|
$2.19 | $1.52 | -30.91% | 2.4M | 613.9M |
United States Sector Performance During 1994
Basic Materials
Technology
Industrials
Healthcare
Communication Services
Energy
Financial Services
Real Estate
Consumer Defensive
Consumer Cyclical
Utilities
Data is updated regularly. Yearly performance is calculated based on closing prices.